How have MVRBF shares performed in 2024?

Medivir AB (publ)'s stock was trading at $0.82 at the start of the year. Since then, MVRBF shares have increased by 0.0% and is now trading at $0.82. View the best growth stocks for 2024 here .

How do I buy shares of Medivir AB (publ)?

Shares of MVRBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:MVRBF

Medivir AB (publ) (MVRBF) Stock Price, News & Analysis

→ This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad)

Free MVRBF Stock Alerts

$0.82

0.00 (0.00%)

(As of 06/15/2023)

Compare

Today's Range: $0.82
▼
$0.82
50-Day Range: $0.82
▼
$0.82
52-Week Range: $0.68
▼
$0.82

Volume: N/A
Average Volume: 925 shs
Market Capitalization: N/A

P/E Ratio: 0.03
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Medivir AB (publ) alerts:

Ad Behind the Markets

Pentagon contract could send this $2 AI stock soaring

Whenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...

Get all the info here >>>

About Medivir AB (publ) Stock (OTCMKTS:MVRBF)

Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of treatments for cancer in Nordic region, rest of Europe, and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It is also developing Remetinostat for treating MF cutaneous T-cell lymphoma and basal cell carcinoma, as well as squamous cell carcinoma. In addition, the company is developing MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors, as well as USP-1/TNG348, USP-7, and MBLI/MET-X, which completed preclinical trials for treating cancer and infection. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.

MVRBF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MVRBF Stock News Headlines

February 26, 2024 | prnewswire.com

Change in Medivir's nomination committee before the 2024 AGM

See More Headlines

Receive MVRBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medivir AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: OTCMKTS:MVRBF
CUSIP: N/A
CIK: N/A
Web: www.medivir.com
Phone: (685) 468-3100
Fax: N/A
Employees: 10
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 0.03
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Jens Lindberg (Age 52)
Chief Exec. Officer
Mr. Magnus Christensen (Age 49)
Chief Financial Officer
Mr. Fredrik Öberg (Age 58)
Chief Scientific Officer & Chief Medical Officer
Ms. Pia Baumann (Age 57)
Chief Medical Officer
Karin Tunblad
Sr. Principal Scientist & MIV-818 Project Leader

Key Competitors

View All Competitors

MVRBF Stock Analysis - Frequently Asked Questions

How have MVRBF shares performed in 2024?: Medivir AB (publ)'s stock was trading at $0.82 at the start of the year. Since then, MVRBF shares have increased by 0.0% and is now trading at $0.82.
View the best growth stocks for 2024 here.
How do I buy shares of Medivir AB (publ)?: Shares of MVRBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:MVRBF) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial